RecruitingMajor Depressive Disorder
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Eligible age
18+ yrs
Accepts
All genders
Locations
10 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in participants with MDD.
Sponsor: Neurocrine Biosciences
Where it's recruiting
California
Oceanside · San Jose
Connecticut
New Haven
Florida
Miami Gardens · Orlando · Palm Bay · Tampa
Louisiana
Marrero
Missouri
O'Fallon
New Mexico
Albuquerque
North Carolina
Charlotte
Oklahoma
Edmond · Oklahoma City
Texas
Bellaire · Friendswood · Stafford · Wichita Falls
Utah
Draper
Source: ClinicalTrials.gov · NCT07196501 · last updated 2026-03-19